Failings Of Clinical Trials, Adaptive Pathways Dominate NGO Conference
Executive Summary
Speakers at a conference organized by Health Action International highlighted ongoing concerns over the commercial nature of clinical trials, the growing trend to conduct trials in low and middle income countries, and perceived failings of the European Medicines Agency’s adaptive pathways initiative.
You may also be interested in...
EMA Defends Adaptive Pathways Against Fresh Attack Following Pilot Report
The European Medicines Agency has dismissed a call to stop accepting applications for its adaptive pathways program until it has better evidence on how to use real-world data.
Denmark Planning To Impose Drug Stockpiling Obligations From July
A new bill is intended to address the increase in medicine supply problems in Denmark in recent years.
National Drug Stockpiles Create ‘False Sense Of Security’
The generics and biosimilars industry body Medicines for Europe says disparate national stockpiling requirements are not a solution to shortages and can bring “significant risks” for the supply chain and access to medicines.